🇰🇷

ToolGen

Public

Korea's CRISPR pioneer

ToolGen is a South Korean gene editing company and one of the original CRISPR patent holders. The company develops CRISPR-Cas9, ZFN, and TALEN technologies for therapeutic applications and has partnerships with major global pharmaceutical companies.

Founded1999

HQSeoul, South Korea

CEOKim Jin-Soo

TickerKOSDAQ:199800

Total Funding$150M

Pipeline

Drug / Program	Indication	Phase	Technology
TG-001	HPV-related cervical neoplasia	Phase 1	CRISPR-Cas9

Key People

Kim Jin-SooFounder & CSO